Carcidiag Biotechnologies develops a diagnostic, fast, sensitive, specific and innovative tool for the detection of precancerous cells for the prevention of carcinogenesis affecting the ENT sphere (tongue, pharynx, oral mucosa), the colorectal area and the lungs as well as the gynecological cancers.

Shenzhen Gedaosu Biotechnology Co., Ltd., established on 2019-10-10, Business scope includes general business items:Glycobiotechnology research,to develop,Technical Services,technology transfer;Operating import and export business,The licensing program is:Production of kits,Sales;Production of biological reagents,operate

URSAPHARM Arzneimittel GmbH & Co. KG manufactures pharmaceutical and medical products for general practice, opthalmology, and rhinology sectors. It offers allergy, ocular vitamins, eyelid inflammation, dry eye syndrome, hysan nasal health, and food supplements. The company was founded in 1974 and is headquartered in Saarbrücken, Germany.

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Green Cross Co., Ltd. engages in the manufacture, sale, and rental of safety items. Its products include road safety materials, disaster prevention necessities, safety equipment, protection gear, and signboards and tags. The company was founded in January 1969 and is headquartered in Fukuoka, Japan.

Part of Sekisui Chemical Co., Ltd., Sekisui Medical Co., Ltd. is a Japanese company located in Tokyo that manufactures and markets in-vitro diagnostic substances and pharmaceutical products. It was acquired by Sekisui Chemical Co., Ltd. from Daiichi Sankyo Co., Ltd. on October 02, 2006.

MediWound is a biotechnology niche-specialty company. Established in 2001, MediWound is focused on developing, manufacturing, and globally commercializing innovative products that address unmet needs in the fields of severe burns and chronic wound management. MediWound’s goal is to provide healthcare professionals and patients with its innovative burn wound eschar removal agent, NexoBrid. NexoBrid successfully completed clinical development in hospitalized burn wounds and is approved and ready to launch in Europe.

Ichimaru Pharcos Co. Ltd. is a Japanese private company. The firm specializes in research and development, manufacturing and selling of raw materials for cosmetics, health foods and quasi drugs.

Peking Union Medical College Hospital, also known as Beijing Xiehe Hospital (Chinese: 北京协和医院), is a renowned general hospital in Beijing, China. It was founded in 1921 by Rockefeller Foundation and is affiliated to both Peking Union Medical College (PUMC) and Chinese Academy of Medical Sciences (CAMS). During the Cultural Revolution, it was renamed the "Anti-imperialist Hospital".

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.